Lung ultrasound monitoring in patients with COVID-19 on home isolation
Lung ultrasound monitoring in patients with COVID-19 on home isolation
复制标题
DOI：
10.1016/j.ajem.2020.05.079
复制
发表时间：
2020-12-01
影响因子：
3.6
通讯作者：
Tung-Chen, Yale
中科院分区：
文献类型：
--
作者：
Shokoohi, Hamid;Duggan, Nicole M.;Tung-Chen, Yale
许多COVID-19患者（由SARS-CoV-2感染引起的临床疾病）表现出轻微症状，不需要住院治疗。相反，这些患者往往被称为14天的家庭隔离症状解决。肺部超声是急诊科和重症监护室评估患者肺部病理的重要手段。超声波也被用于评估收治的COVID-19患者。然而，缺乏关于COVID-19患者居家隔离的超声检查结果进展的数据。在这里，我们介绍了一组患有COVID-19的医生患者的病例系列，这些患者在家庭隔离期间使用肺部床旁超声（POCUS）进行每日自我监测。在14天隔离期内，肺部POCUS结果与所有3名确诊COVID-19患者的症状发作和缓解一致。肺POCUS可能为监测居家隔离的COVID-19患者提供一种可行的方法。将超声检查结果与疾病进展和预后相关联的进一步研究将是有价值的。(C)2020由Elsevier Inc.出版。
Many patients with COVID-19, the clinical illness caused by SARS-CoV-2 infection, exhibit mild symptoms and do not require hospitalization. Instead, these patients are often referred for 14-days of home isolation as symptoms resolve. Lung ultrasound is well-established as an important means of evaluating lung pathology in patients in the emergency department and in intensive care units. Ultrasound is also being used to assess admitted patients with COVID-19. However, data on the progression of sonographic findings in patients with COVID-19 on home isolation is lacking. Here we present a case series of a group of physician patients with COVID-19 who monitored themselves daily while in home isolation using lung point-of-care ultrasound (POCUS). Lung POCUS findings corresponded with symptom onset and resolution in all 3 patients with confirmed COVID-19 during the 14-day isolation period. Lung POCUS may offer a feasible means of monitoring patients with COVID-19 who are on home isolation. Further studies correlating sonographic findings to disease progression and prognosis will be valuable. (C) 2020 Published by Elsevier Inc.